Q/C Technologies director receives RSUs and options

Q/C Technologies director Chelsea Sierra Voss reported new equity awards.

Rhea-AI Filing Summary

Q/C Technologies director Chelsea Sierra Voss reported new equity awards. On January 16, 2026, she received 212,500 shares of common stock as restricted stock units under a consulting agreement and 25,000 additional RSU shares tied to her appointment to the board. Both RSU grants vest in four equal quarterly installments if she continues providing services.

She also received an employee stock option for 212,500 shares of common stock at an exercise price of $5.097 per share, vesting quarterly on the same schedule. Following these awards, she beneficially owns 239,900 shares of common stock directly and 59,802 shares indirectly through a Roth IRA, plus 212,500 stock options.

Insider Trade Summary

Grant/Award: 450,000 shares

Grant/Award 4 txns

Insider Voss Chelsea Sierra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	212,500	$0.00	$0.00
Grant/Award	Common stock	212,500	$0.00	$0.00
Grant/Award	Common stock	25,000	$0.00	$0.00
holding	Common stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 212,500 contracts (Direct); Common stock — 239,900 shares (Direct); Common stock — 59,802 shares (Indirect, By Roth IRA)

Footnotes (3)

1. F1. Represents a grant of Restricted Stock Units ("RSUs") issued pursuant to a consulting agreement, dated January 16, 2026, by and between the Issuer and the Reporting Person (the "Consulting Agreement"). The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.
2. F2. Represents a grant of RSUs issued in connection with the appointment of the Reporting Person as director of the Issuer's board of directors. The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates.
3. F3. The stock options were granted pursuant to the Consulting Agreement and will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Q/C Technologies (QCLS) report for Chelsea Sierra Voss?

Q/C Technologies director Chelsea Sierra Voss reported receiving new equity awards on January 16, 2026. She was granted restricted stock units and stock options, increasing her direct and indirect beneficial ownership in the company’s common stock and aligning compensation with ongoing service.

How many Q/C Technologies (QCLS) shares did Chelsea Sierra Voss receive as RSUs?

Chelsea Sierra Voss received 212,500 shares as restricted stock units under a consulting agreement and 25,000 RSU shares related to her board appointment. Both grants vest in four equal quarterly installments, contingent on her continuing to provide services to Q/C Technologies.

What stock option grant did Chelsea Sierra Voss receive from Q/C Technologies (QCLS)?

She received an employee stock option for 212,500 shares of Q/C Technologies common stock at an exercise price of $5.097 per share. The options vest in four substantially equal quarterly installments, conditioned on her continued employment or service to the company.

How many Q/C Technologies (QCLS) shares does Chelsea Sierra Voss beneficially own after the grants?

After the reported grants, Chelsea Sierra Voss beneficially owns 239,900 shares of Q/C Technologies common stock directly. She also holds 59,802 additional shares indirectly through a Roth IRA, plus 212,500 stock options that may be exercised in the future subject to vesting.

What are the vesting conditions for Chelsea Sierra Voss’s RSUs from Q/C Technologies (QCLS)?

The RSUs granted to Chelsea Sierra Voss vest in four substantially equal installments on each quarterly anniversary of the grant date. Vesting requires that she remain employed by, or continue providing services to, Q/C Technologies through each applicable vesting date.

Are Chelsea Sierra Voss’s option grants from Q/C Technologies (QCLS) tied to a consulting agreement?

Yes. The employee stock options for 212,500 shares were granted under a consulting agreement dated January 16, 2026. These options vest in four quarterly installments, provided she continues to be employed by or provide services to Q/C Technologies through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 05:31 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Voss Chelsea Sierra

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS, SUITE 249

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Q/C TECHNOLOGIES, INC. [ QCLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	01/16/2026		A		212,500	A	$0(1)	214,900	D
Common stock	01/16/2026		A		25,000	A	$0(2)	239,900	D
Common stock								59,802	I	By Roth IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$5.097	01/16/2026		A		212,500		(3)	01/16/2036(3)	Common Stock	212,500	$0	212,500	D

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs") issued pursuant to a consulting agreement, dated January 16, 2026, by and between the Issuer and the Reporting Person (the "Consulting Agreement"). The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.

2. Represents a grant of RSUs issued in connection with the appointment of the Reporting Person as director of the Issuer's board of directors. The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates.

3. The stock options were granted pursuant to the Consulting Agreement and will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates.

	/s/ Chelsea Sierra Voss	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.